The Role of Serum Cytokines IL_17 A and IL_10 in Disease Activity of Acute B Lymphoblastic Leukemia in South Egypt
Starting soon
Conditions studied: Acute Lymphoblastic Leukemia, B-Cell
In brief
Study aimsTo measure the serum levels of IL-17 A and IL-10 in newly diagnosed patients with B-cell acute lymphoblastic leukemia (B-ALL). 2-To study the association between serum cytokine levels (IL-17 A and IL-10) and laboratory parameters, as well as the response to treatment
Key facts
- Study ID
- NCT07509385
- Run by
- Assiut University
- People needed
- 80
- Starts
- 2026-03-31
- Expected to finish
- 2027-05-29
- Last updated by the study team
- 2026-04-03
Who can join
Age: any. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- Newly diagnosed acute B lymphoblastic leukemia patient
You may not qualify if…
- patients who received chemotherapy or immunotherapy
- patients with other malignancies
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.